Evidence map›Paper›PMID 22618436›Full record

ArticleCurrent genetics2012

A TRP5/5-fluoroanthranilic acid counter-selection system for gene disruption in Candida guilliermondii.

Emilien Foureau, Marc Clastre, Yoann Millerioux, Andrew J Simkin, Lucie Cornet, Christelle Dutilleul, Sébastien Besseau, Emeline Marais, Céline Melin, Jérôme Guillard and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Current genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Optimization of Protoplast Preparation Conditions inJournal of fungi (Basel, Switzerland) · 2024
    Article
  2. Expanding the Toolbox for Functional Genomics inJournal of fungi (Basel, Switzerland) · 2023
    Article
  3. Oxidative stress response pathways in fungi.Cellular and molecular life sciences : CMLS · 2022
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Emilien FoureauBiomolécules et Biotechnologies Végétales, UFR Pharmacie, Université François Rabelais de Tours, EA2106, Tours, France.
Marc Clastre
Yoann Millerioux
Andrew J Simkin
Lucie Cornet
Christelle Dutilleul
Sébastien Besseau
Emeline Marais
Céline Melin
Jérôme Guillard
Joël Crèche
Nathalie Giglioli-Guivarc'h
Vincent Courdavault
Nicolas Papon
Université de Tours · FRCentre de Résonance Magnétique des Systèmes Biologiques · FRLaboratoire de Chimie Organique · FRUniversity of Essex · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida guilliermondii is an interesting biotechnological model for the industrial production of value-added metabolites and also remains an opportunistic emerging fungal agent of candidiasis often associated with oncology patients. The aim of the present study was to establish a convenient transformation system for C. guilliermondii by developing both an ATCC 6260-derived recipient strain and a recyclable selection marker. We first disrupted the TRP5 gene in the wild-type strain and demonstrated that trp5 mutants were tryptophan auxotroph as well as being resistant to the antimetabolite 5-fluoroanthranilic acid (FAA). Following an FAA selection of spontaneous mutants derived from the ATCC 6260 strain and complementation analysis, we demonstrated that trp5 genotypes could be directly recovered on FAA-containing medium. The TRP5 wild-type allele, flanked by two short repeated sequences of its 3'UTR, was then used to disrupt the FCY1 gene in C. guilliermondii trp5 recipient strains. The resulting fcy1 mutants displayed strong flucytosine resistance and a counter-selection on FAA allowed us to pop-out the TRP5 allele from the FCY1 locus. To illustrate the capacity of this blaster system to achieve a second round of gene disruption, we knocked out both the LEU2 and the HOG1 genes in the trp5, fcy1 background. Although all previously described yeast "TRP blaster" disruption systems used TRP1 as counter-selectable marker, this study demonstrated the potential of the TRP5 gene in such strategies. This newly created "TRP5 blaster" disruption system thus represents a powerful genetic tool to study the function of a large pallet of genes in C. guilliermondii.

Indexed as

Gene Expression Regulation, FungalMultigene FamilyCandidaFungal ProteinsGenetic MarkersMutationortho-AminobenzoatesTRPC Cation Channelsanthranilic acidFungal ProteinsGenetic Markersortho-AminobenzoatesTRPC Cation Channels

Identifiers

PMID22618436
OpenAlexW1971836270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.